PLoS ONE (Jul 2007)

Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection.

  • Michaela Lucas,
  • Axel Ulsenheimer,
  • Katja Pfafferot,
  • Malte H J Heeg,
  • Silvana Gaudieri,
  • Norbert Grüner,
  • Andri Rauch,
  • J Tilman Gerlach,
  • Maria-Christina Jung,
  • Reinhart Zachoval,
  • Gerd R Pape,
  • Winfried Schraut,
  • Teresa Santantonio,
  • Hans Nitschko,
  • Martin Obermeier,
  • Rodney Phillips,
  • Thomas J Scriba,
  • Nasser Semmo,
  • Cheryl Day,
  • Jonathan N Weber,
  • Sarah Fidler,
  • Robert Thimme,
  • Anita Haberstroh,
  • Thomas F Baumert,
  • Paul Klenerman,
  • Helmut M Diepolder

DOI
https://doi.org/10.1371/journal.pone.0000649
Journal volume & issue
Vol. 2, no. 7
p. e649

Abstract

Read online

CD4+ T cell help is critical in maintaining antiviral immune responses and such help has been shown to be sustained in acute resolving hepatitis C. In contrast, in evolving chronic hepatitis C CD4+ T cell helper responses appear to be absent or short-lived, using functional assays.Here we used a novel HLA-DR1 tetramer containing a highly targeted CD4+ T cell epitope from the hepatitis C virus non-structural protein 4 to track number and phenotype of hepatitis C virus specific CD4+ T cells in a cohort of seven HLA-DR1 positive patients with acute hepatitis C in comparison to patients with chronic or resolved hepatitis C. We observed peptide-specific T cells in all seven patients with acute hepatitis C regardless of outcome at frequencies up to 0.65% of CD4+ T cells. Among patients who transiently controlled virus replication we observed loss of function, and/or physical deletion of tetramer+ CD4+ T cells before viral recrudescence. In some patients with chronic hepatitis C very low numbers of tetramer+ cells were detectable in peripheral blood, compared to robust responses detected in spontaneous resolvers. Importantly we did not observe escape mutations in this key CD4+ T cell epitope in patients with evolving chronic hepatitis C.During acute hepatitis C a CD4+ T cell response against this epitope is readily induced in most, if not all, HLA-DR1+ patients. This antiviral T cell population becomes functionally impaired or is deleted early in the course of disease in those where viremia persists.